A carregar...
Modulation of host metabolism as a target of new antivirals()
The therapy for chronic hepatitis C (CH–C) started with interferon (IFN) monotherapy in the early 1990s and this therapy was considered effective in about 10% of cases. The present standard therapy of pegylated IFN with ribavirin achieves a sustained virologic response in about 50% of patients. Howe...
Na minha lista:
| Publicado no: | Adv Drug Deliv Rev |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier B.V.
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7103349/ https://ncbi.nlm.nih.gov/pubmed/17897752 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2007.03.021 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|